Approaching Dana Faber Cancer Institute

• by EVOMT
• 2023-02-06

Hospital Introduction

Dana Faber Cancer Research Institute was established in 1947 as a cancer specialist affiliated hospital of Harvard Medical School in the United States and a comprehensive cancer treatment center designated by the United States federal government. It has produced one Nobel Prize winner in medicine. It is a world leader in clinical aspects such as cancer gene targeting therapy, cancer immunotherapy, cancer endocrine therapy, cancer biological therapy, and cancer vaccine.

Since its establishment, Dana Faber Cancer Research Institute has been committed to providing professional and best medical services to cancer patients, while improving the understanding, diagnosis, treatment, and prevention of cancer and related diseases through cutting-edge research. As an affiliated hospital of Harvard Medical School and a comprehensive cancer center designated by the United States federal government, Dana Faber Cancer Research Institute also trains a new generation of doctors and experts to improve public health care in high-risk areas and areas with low medical standards, and promotes advanced treatment methods and scientific discoveries throughout the United States and the world.

Currently, the Dana Faber Cancer Institute has 4000 staff and receives approximately 300000 patients annually. Each year, more than 700 clinical trials are available for selection, and they are renowned worldwide for their dual advantages in clinical and research.

Highlight achievements

In 1996, Bregan and Women's Hospital established the Dana Faber/Bregan Cancer Center in collaboration with the Dana Faber Cancer Research Institute, a leading cancer treatment and research institution in the world. Outpatients for cancer patients are conducted at the Dana Faber Cancer Institute, while inpatient treatment is conducted at the Bregan and Women's Hospital. The two institutions are connected by an overpass and integrated to form the Dana Faber/Bregan Cancer Center. Has been rated as the top and most authoritative cancer treatment center in the United States.

Dana Farber/Bregen Cancer Center has integrated the world's top cancer research institutes and a world's top hospital, and created 12 cancer specialties integrating comprehensive medical treatment, surgery, radiotherapy and the latest clinical trials, which can treat lung cancer, breast cancer, gastric cancer, food tube cancer, colorectal cancer, liver cancer, pancreatic cancer, leukemia, multiple myeloma, nervous system tumors, prostate cancer, kidney cancer, cervical cancer, osteosarcoma Head and neck cancer, skin cancer, melanoma, and so on. Its milestone achievements include:

Developed the first and only biomarker CA-125 test for ovarian cancer;

Take the lead in developing new methods for evaluating and treating prostate cancer;

Developed the most advanced brain surgery tumor surgery technology;

Selective internal radiation therapy was first performed on the liver.

Scientific Research

Dana Farber, founder of the Institute, Sidney Farber, MD)'s vision is to provide skilled and compassionate care to patients while committing to cancer based research and exploration.

The Institute has made strategic investment in scientific research, fully supporting scientific leaders and young researchers in their grand plans, promoting the progress of new therapies, and implementing a spirit of teamwork and innovation. Research fund sponsored by the National Institutes of Health（ 136 NIH Sponsored Research Grants, 594 researchers, 70 clinical researchers (adult and pediatric oncology), and 156 chief researchers Over 1100 open clinical trials.

Highlight Honors

Dana Faber is a founding member of the Harvard Cancer Center, one of the 49 comprehensive cancer centers designated by the National Cancer Institute (NCI) in the United States;

One of the chief teaching hospitals of Harvard Medical School;

One of the 19 AIDS research centers designated by the United States federal government;

The only hospital in the United States that ranked among the top four in the U.S. in both adult and pediatric cancer care specialties on the U.S. News and World Report list;

The research institute that has received the most academic grants from the National Cancer Institute (NCI) of the United States;

Dana Faber has the highest number of research citations among the leading cancer centers in the United States.

Has been rated as the top and most authoritative cancer treatment center in the United States;

The treatment of childhood tumors has ranked first in the United States over the years;

A comprehensive cancer treatment center designated by the United States federal government.

Cooperation direction

1. Hospital Management Training

2. Clinical Subject Training

3. Clinical Observation and Training

4. Discipline co construction - tumor center co construction

5. Experts invited to visit China